• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞症(VTE)治疗后的死亡率和复发率:具有良好预期寿命的患者的长期随访。

Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy.

机构信息

Oslo University Hospital, Aker, Norway.

出版信息

Thromb Res. 2011 Jun;127(6):540-6. doi: 10.1016/j.thromres.2011.02.017. Epub 2011 Mar 24.

DOI:10.1016/j.thromres.2011.02.017
PMID:21435698
Abstract

INTRODUCTION

After completed anticoagulant treatment for acute VTE, both the subsequent mortality and risk of recurrent VTE are high, probably related to the frequent presence of serious disease in these patients. The aim of the study was to determine survival and recurrence in selected patients with good life-expectancy, and to evaluate risk factors.

METHODS

The 323 patients were followed for median 7.4 years (range 4.1-11.9) after cessation of anticoagulation. Survival analysis and Cox-regression were used for univariate and multivariate analysis.

RESULTS

The cumulative incidence of survival after 5 years was 93.4%. Standardised mortality ratio was 1.42 for men and 1.28 for women. Patients without a transient risk factor prior to the index VTE were associated with higher risk of mortality compared to risk of mortality in patients with a transient risk factor (hazard ratio (HR) 2.81; 95% CI 1.40-5.62). Recurrence of VTE after 5 years was 19.0%. A persistent risk factor or a spontaneous VTE was associated with higher risk of recurrence compared to a transient risk factor (HR 2.39; 95% CI 1.44-3.95). Elevated D-dimer levels increased the risk, and immobilisation prior to the index VTE reduced the risk of recurrence. Sex, age and thrombophilia were not independent risk factors for recurrence.

CONCLUSIONS

Despite a low mortality rate in this selected cohort, the recurrence rate and risk factors for recurrence were similar to findings reported in unselected populations. VTE unrelated to a transient risk factor was associated with increased mortality compared to mortality in patients with a transient risk factor.

摘要

简介

急性静脉血栓栓塞症(VTE)抗凝治疗结束后,患者的后续死亡率和复发性 VTE 风险均较高,这可能与这些患者常患有严重疾病有关。本研究旨在确定具有良好预期寿命的选定患者的生存和复发情况,并评估相关风险因素。

方法

323 例患者在停止抗凝治疗后中位随访 7.4 年(4.1-11.9 年)。采用生存分析和 Cox 回归进行单因素和多因素分析。

结果

5 年后的累积生存率为 93.4%。男性的标准化死亡率比为 1.42,女性为 1.28。与有一过性危险因素的患者相比,无首发 VTE 前一过性危险因素的患者的死亡率更高(风险比(HR)2.81;95%CI 1.40-5.62)。5 年后 VTE 复发率为 19.0%。持续性危险因素或自发性 VTE 与一过性危险因素相比,复发风险更高(HR 2.39;95%CI 1.44-3.95)。D-二聚体水平升高会增加风险,而首发 VTE 前的固定会降低复发风险。性别、年龄和血栓形成倾向不是复发的独立危险因素。

结论

尽管在这个选定的队列中死亡率较低,但复发率和复发风险因素与未选择人群的报告相似。与有一过性危险因素的患者相比,无一过性危险因素的 VTE 与死亡率增加相关。

相似文献

1
Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy.静脉血栓栓塞症(VTE)治疗后的死亡率和复发率:具有良好预期寿命的患者的长期随访。
Thromb Res. 2011 Jun;127(6):540-6. doi: 10.1016/j.thromres.2011.02.017. Epub 2011 Mar 24.
2
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.患者水平荟萃分析:D-二聚体检测评估不明原因静脉血栓栓塞后复发风险时,检测时机、阈值和患者年龄对其能力的影响。
Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009.
3
Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.性别和传统心血管危险因素对复发性静脉血栓栓塞风险的影响:来自德国MAISTHRO注册研究的结果
Blood Coagul Fibrinolysis. 2008 Mar;19(2):159-65. doi: 10.1097/MBC.0b013e3282f54558.
4
Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years.50岁以下患者复发性静脉血栓栓塞的长期前瞻性研究。
Pathophysiol Haemost Thromb. 2005;34(1):6-12. doi: 10.1159/000088541.
5
Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry.急性静脉血栓栓塞症患者的长期死亡和复发:MASTER 登记研究。
Thromb Res. 2012 Sep;130(3):369-73. doi: 10.1016/j.thromres.2012.04.003. Epub 2012 May 13.
6
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.D-二聚体检测对既往有特发性事件的受试者及先天性血栓形成倾向携带者抗凝治疗停药后复发性静脉血栓栓塞的预测价值
Circulation. 2003 Jul 22;108(3):313-8. doi: 10.1161/01.CIR.0000079162.69615.0F. Epub 2003 Jul 7.
7
Long-term prospective study of recurrent venous thromboembolism in a Hispanic population.西班牙裔人群复发性静脉血栓栓塞的长期前瞻性研究。
Blood Coagul Fibrinolysis. 2010 Oct;21(7):660-5. doi: 10.1097/MBC.0b013e32833ceaef.
8
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.急性后期护理患者静脉血栓栓塞症的发生率及预测因素。一项前瞻性队列研究。
Thromb Haemost. 2010 Oct;104(4):734-40. doi: 10.1160/TH10-03-0169. Epub 2010 Jul 20.
9
Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.在无因子 V 莱顿突变的情况下,凝血酶生成和活化蛋白 C 抵抗与 18-65 岁女性复发性静脉血栓栓塞风险相关。
Thromb Haemost. 2011 Nov;106(5):901-7. doi: 10.1160/TH11-04-0254. Epub 2011 Sep 22.
10
Sex-specific risk factors for recurrent venous thromboembolism.性别特异性复发性静脉血栓栓塞的风险因素。
Thromb Res. 2012 Jul;130(1):16-20. doi: 10.1016/j.thromres.2011.10.026. Epub 2011 Nov 17.

引用本文的文献

1
Long-Term Efficacy and Safety of Direct Oral Anticoagulants at Reduced Doses in the Secondary Prevention of Venous Thromboembolism and Post-Thrombotic Syndrome.低剂量直接口服抗凝剂在静脉血栓栓塞症二级预防和血栓后综合征中的长期疗效及安全性
J Clin Med. 2024 Apr 19;13(8):2394. doi: 10.3390/jcm13082394.
2
Editorial: Highlights in Thrombosis: 2021.社论:2021年血栓形成研究亮点。
Front Cardiovasc Med. 2022 Feb 24;9:863030. doi: 10.3389/fcvm.2022.863030. eCollection 2022.
3
Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism.
静脉血栓栓塞症患者不良结局、大出血和全因死亡率的危险因素
Vasc Specialist Int. 2021 Dec 31;37:46. doi: 10.5758/vsi.210041.
4
Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study.静脉血栓栓塞症后的长期生存:一项前瞻性队列研究。
Front Cardiovasc Med. 2021 Oct 1;8:749342. doi: 10.3389/fcvm.2021.749342. eCollection 2021.
5
Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis.平均血小板体积与肺栓塞之间的关联:一项系统评价和荟萃分析。
Aging (Albany NY). 2021 Jul 2;13(13):17253-17273. doi: 10.18632/aging.203205.
6
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.首次无诱因静脉血栓栓塞事件停止抗凝治疗后症状性复发性静脉血栓栓塞的长期风险:系统评价和荟萃分析。
BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.
7
Progress in the research on venous thromboembolism.静脉血栓栓塞症的研究进展
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):811-815. doi: 10.1007/s11596-017-1811-z. Epub 2017 Dec 21.
8
Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of GCC-4401C, a Novel Direct Factor Xa Inhibitor, in Healthy Volunteers.新型直接凝血因子Xa抑制剂GCC-4401C在健康志愿者中的群体药代动力学和药效学建模分析
CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):532-543. doi: 10.1002/psp4.12103. Epub 2016 Aug 11.
9
Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.凝血因子XIIIa的变构抑制。非糖类糖胺聚糖模拟物而非糖胺聚糖展现出有前景的抑制特性。
PLoS One. 2016 Jul 28;11(7):e0160189. doi: 10.1371/journal.pone.0160189. eCollection 2016.
10
The epidemiology of venous thromboembolism.静脉血栓栓塞症的流行病学
J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6.